The review said a certain class of drugs had little clinical benefit, but many Alzheimer’s experts criticized the analysis, saying it unfairly lumped failed drugs with two recently approved treatments.
Health
·
Analysis of Alzheimer’s Drugs Stirs Debate About Their Effectiveness
CN
CitrixNews Staff
Originally reported by New York Times. Read the full story at the original source.
Related Articles
Health
How to treat heat exhaustion
How to treat heat exhaustionTo play this video you need to enable JavaScript in your browser.This video can not be playe...
CitrixNews Staff
·
10 hours ago
Health
The Guardian view on the Ockenden maternity review: lifting standards must be the number one priority | Editorial
Families are right to be angry about devastating care failures in Nottingham. Ministers must respond fastThe painful fam...
CitrixNews Staff
·
10 hours ago
Health
‘Infection control becomes almost impossible’: four doctors on the NHS heatwave crisis
Frontline medics describe extreme heat conditions they feel are unsafe and lacking in dignity for patientsHospitals in E...
CitrixNews Staff
·
11 hours ago
Health
Belittled, ignored or gaslit – now we know the true cost of not listening to pregnant women | Rhiannon Lucy Cosslett
The Ockenden report tells a terrible story of neglect. It’s a story that I – and far too many women I know – recogniseTh...
CitrixNews Staff
·
14 hours ago